InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

Current share price for AVR : $11.810 0.13 (1.11%)+

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$172 Change of Director's Interest Notice x 4 20 Sep 2023 3:12PM $20.000 $11.810 fallen by 40.95%
$172 Notification regarding unquoted securities - AVR 19 Sep 2023 5:56PM $20.300 $11.810 fallen by 41.82%
$172 Anteris to Present at Cantor Healthcare Conference 12 Sep 2023 5:19PM $21.100 $11.810 fallen by 44.03%
$172 Results of Meeting 6 Sep 2023 11:53AM $20.900 $11.810 fallen by 43.49%
$172 Cleansing Notice 4 Sep 2023 9:07AM $21.020 $11.810 fallen by 43.82%
$172 Application for quotation of securities - AVR 1 Sep 2023 8:57AM $21.000 $11.810 fallen by 43.76%
$172 Appendix 4D and Half Year Financial Report Announcement 25 Aug 2023 4:59PM $20.500 $11.810 fallen by 42.39%
$172 Appendix 4D and Half Year Financial Report 25 Aug 2023 4:58PM $20.500 $11.810 fallen by 42.39%
$172 Cleansing Notice 18 Aug 2023 4:23PM $19.100 $11.810 fallen by 38.17%
$172 Application for quotation of securities - AVR 18 Aug 2023 11:58AM $19.400 $11.810 fallen by 39.12%
$172 Exceptional Results in Second Valve-in-Valve Case 14 Aug 2023 9:37AM $20.750 $11.810 fallen by 43.08%
$172 Notification of cessation of securities - AVR 9 Aug 2023 4:54PM $20.210 $11.810 fallen by 41.56%
$172 Notification regarding unquoted securities - AVR 9 Aug 2023 4:47PM $20.210 $11.810 fallen by 41.56%
$172 Commencement of American Depository Receipt Program 9 Aug 2023 12:34PM $19.750 $11.810 fallen by 40.20%
$172 Montefiore enrolls Patients in US Early Feasibility Study 9 Aug 2023 9:39AM $19.990 $11.810 fallen by 40.92%
$172 Notice of Extraordinary General Meeting/Proxy Form 7 Aug 2023 4:19PM $20.130 $11.810 fallen by 41.33%
$172 DurAVR first successful implantation Valve-in-Valve 31 Jul 2023 8:32AM $21.000 $11.810 fallen by 43.76%
$172 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 4:28PM $21.000 $11.810 fallen by 43.76%
$172 Notification of cessation of securities - AVR 20 Jul 2023 10:25AM $21.000 $11.810 fallen by 43.76%
$172 Cleansing Notice 13 Jul 2023 6:16PM $19.050 $11.810 fallen by 38%
$172 Application for quotation of securities - AVR 13 Jul 2023 6:03PM $19.050 $11.810 fallen by 38%
$172 Cleansing Notice 29 Jun 2023 9:44AM $20.990 $11.810 fallen by 43.74%
$172 Application for quotation of securities - AVR 29 Jun 2023 9:30AM $20.990 $11.810 fallen by 43.74%
$172 Cleansing Notice 22 Jun 2023 9:41AM $21.750 $11.810 fallen by 45.70%
$172 Application for quotation of securities - AVR 22 Jun 2023 9:36AM $21.750 $11.810 fallen by 45.70%

326 - 350 of 713 results

Page 14 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.